Large-scale testing (Phase 3)Study completedNCT03813238
What this trial is testing
TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
Who this might be right for
Cerebral Palsy, Dyskinetic
Teva Branded Pharmaceutical Products R&D, Inc. 63